Assay Development

Next Generation Predictive Tests

Eutropics is implementing a patented approach for detecting Bcl-2 family dependencies in solid and liquid tumors. The new flow cytometry, immunofluorescence (IF) and immunohistochemistry (IHC) based format will soon be available to blood cancer and solid tumor clinical investigators and pharmaceutical companies.